Climate Health Pharma

Air, freshwater, soil becoming saltier, posing an ‘existential threat’

HQ Team November 6, 2023: Human activities are making the earth’s air, freshwater and soil saltier, posing an “existential threat” if the trend

Read More
Drugs Health Pharma

One in seven people in US reports having long Covid by the end of 2022

HQ Team November 6, 2023: One in seven people in the US has had long Covid by the end of 2022, according to

Read More
Drugs Health Pharma

Zoliflodacin shows potential in treating drug-resistant super gonorrhea

HQ Team November 4, 2023: Scientists have discovered a possible treatment for antibiotic-resistant super gonorrhea. In a large experiment involving nearly a 1000

Read More
Drugs Health Medical

Novel long-acting GLP-1 agonist offers hope for type 2 diabetics

HQ Team November 4, 2023: Scientists at the University of Tabriz, Iran, have done pioneering work on a long-acting GLP-1 agonist that holds

Read More
Drugs Health Medical Pharma

Study finds insulin can be stored at room temp without losing potency

HQ team November 3, 2023: Recent research by Cochrane has found that insulin can maintain its efficacy for extended periods at room temperature.

Read More
Drugs Health Medical

Key metabolite’s role in DNA repair will help cancer treatment

HQ team November 3, 2023: Researchers at Michigan Medicine, University of Michigan, have discovered a key metabolite’s role in regulating DNA repair processes,

Read More
Drugs Health Medical

Researchers create synthetic melanin that heals burn injuries and beyond

HQ team November 3, 2023: Researchers at Northwestern University have developed a synthetic melanin, a versatile pigment found in nature. This synthetic version

Read More
Drugs Health Pharma

GSK to pay $1 billion to acquire exclusive rights for J&J hepatitis B therapy

 HQ Team November 1, 2023: GSK, a British pharmaceutical company, will pay $1 billion to Johnson & Johnson for transferring exclusive global rights

Read More
Drugs Health Pharma

AstraZeneca inks $245 million deal with Cellectis for rare diseases

HQ Team November 1, 2023: AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in

Read More
Drugs Medical Pharma

Clovibactin: A novel antibiotic with greater resistance

HQ Team November 1, 2023: A collaboration between the University of Bonn, Utrecht University, and Northeastern University in Boston, alongside NovoBiotic Pharmaceuticals, has

Read More